For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of this treatment and the formulated version represents a genuine breakthrough . These novel therapies protect the transthyretin protein, halting its damaging build-up and reducing the burden of the disease . Individuals are now seeing benefit… Read More